|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Technical Developments |
1 From the Departments of Diagnostic Radiology (D.B., H.G.H., R.H., G.B.) and Angiology (M.A., K.A.J.), University of Basel, Petersgraben 4, CH-4031 Basel, Switzerland; Biozentrum, University of Basel, Switzerland (A.C.S.); and Hochrheinklinik, Bad Saeckingen, Germany (W.O.D.). Received March 17, 2004; revision requested May 25; revision received June 17; accepted June 28. Address correspondence to D.B. (e-mail: dbilecen@uhbs.ch).
Institutional review board approval and patient consent were obtained. A low-dose injection protocol for intraarterial three-dimensional (3D) gadolinium-enhanced magnetic resonance (MR) angiography was derived from femoral flow phantom studies and prospectively evaluated in patients with peripheral arterial occlusive disease (PAOD). All MR angiograms were obtained at 1.5 T with a T1-weighted gradient-echo sequence. MR angiograms of a gadolinium dilution series (0.8200.0 mmol/L) were acquired in a femoral phantom at different flow rates. Signal-to-noise ratios (SNRs) above the 75% threshold of the measured maximum were considered optimal. The lowest optimal concentration was injected intraarterially in nine patients to obtain 3D MR angiograms of the thigh and calf station. Contrast-to-noise ratios (CNRs) were calculated for four arterial segments. The low optimal concentration of 50 mmol/L (20-mL bolus volume), about 5% of the total permissible dose, showed SNRs larger than the 75% threshold in the phantom study. In patients, this concentration led to high-spatial-resolution angiograms with mean CNRs of 70.0 ± 14.5 (± standard deviation) for the superficial femoral artery and 47.5 ± 13.4 at the infrapopliteal level. Low-dose contrast agent intraarterial 3D MR angiography showed high arterial enhancement, enabling assessment of lower extremity arteries in patients with PAOD and multiple injectionsa crucial precondition for MR-guided endovascular interventions.
© RSNA, 2004
This article has been cited by other articles:
![]() |
S. Potthast, G. M. Bongartz, R. Huegli, A.-C. Schulte, J. G. Schwarz, M. Aschwanden, and D. Bilecen Intraarterial Contrast-Enhanced MR Aortography With and Without Parallel Acquisition Technique in Patients with Peripheral Arterial Occlusive Disease Am. J. Roentgenol., March 1, 2007; 188(3): 823 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Huegli, M. Aschwanden, K. Scheffler, and D. Bilecen Fluoroscopic contrast-enhanced MR angiography with a magnetization-prepared steady-state free precession technique in peripheral arterial occlusive disease. Am. J. Roentgenol., July 1, 2006; 187(1): 242 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Huegli, M. Aschwanden, G. Bongartz, K. Jaeger, H.-G. Heidecker, C. Thalhammer, A.-C. Schulte, C. Hashagen, A. L. Jacob, and D. Bilecen Intraarterial MR Angiography and DSA in Patients with Peripheral Arterial Occlusive Disease: Prospective Comparison Radiology, June 1, 2006; 239(3): 901 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-C. Schulte, G. Bongartz, R. Huegli, M. Aschwanden, K. A. Jaeger, W. Ostheim-Dzerowycz, A. L. Jacob, and D. Bilecen Intraarterial Versus IV Gadolinium Injections for MR Angiography: Quantitative and Qualitative Assessment of the Infrainguinal Arteries Am. J. Roentgenol., September 1, 2005; 185(3): 735 - 740. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |